JP2022535955A5 - - Google Patents

Info

Publication number
JP2022535955A5
JP2022535955A5 JP2021573380A JP2021573380A JP2022535955A5 JP 2022535955 A5 JP2022535955 A5 JP 2022535955A5 JP 2021573380 A JP2021573380 A JP 2021573380A JP 2021573380 A JP2021573380 A JP 2021573380A JP 2022535955 A5 JP2022535955 A5 JP 2022535955A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
disease
substituted
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021573380A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022535955A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/066196 external-priority patent/WO2020249669A1/en
Publication of JP2022535955A publication Critical patent/JP2022535955A/ja
Publication of JP2022535955A5 publication Critical patent/JP2022535955A5/ja
Pending legal-status Critical Current

Links

JP2021573380A 2019-06-12 2020-06-11 スルホンアミド誘導体及びその使用 Pending JP2022535955A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962860661P 2019-06-12 2019-06-12
US62/860,661 2019-06-12
PCT/EP2020/066196 WO2020249669A1 (en) 2019-06-12 2020-06-11 Sulfonamide derivatives and uses thereof

Publications (2)

Publication Number Publication Date
JP2022535955A JP2022535955A (ja) 2022-08-10
JP2022535955A5 true JP2022535955A5 (OSRAM) 2023-06-19

Family

ID=71108564

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573380A Pending JP2022535955A (ja) 2019-06-12 2020-06-11 スルホンアミド誘導体及びその使用

Country Status (5)

Country Link
US (1) US20220267300A1 (OSRAM)
EP (1) EP3983388A1 (OSRAM)
JP (1) JP2022535955A (OSRAM)
CN (1) CN114761383A (OSRAM)
WO (1) WO2020249669A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
SI3983387T1 (sl) 2019-06-12 2024-09-30 NodThera Limited Derivati sulfoniluree in njihove uporabe
ES3056339T3 (en) 2019-06-12 2026-02-19 Nodthera Ltd Sulfonylurea derivatives and uses thereof
EP4559461A1 (en) * 2023-11-22 2025-05-28 Servicio Andaluz De Salud Dual nlrp1 and nlrp3 inhibitors for use as a medicament

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA903210A (en) * 1970-02-03 1972-06-20 Merck Sharp And Dohme (I.A.) Corp. Indole derivatives
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JPH06510763A (ja) * 1991-08-19 1994-12-01 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー アンジオテンシン２受容体遮断イミダゾリノン誘導体
JPH06510762A (ja) * 1991-08-19 1994-12-01 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー アンジオテンシン２受容体遮断イミダゾリノン誘導体
NZ247440A (en) * 1992-05-06 1995-04-27 Squibb & Sons Inc Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
JPH09504508A (ja) * 1993-09-28 1997-05-06 チバ−ガイギー アクチエンゲゼルシャフト 殺虫剤及び殺ダニ剤としてのアクリル化スルホンアミド
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
AR039156A1 (es) * 2002-03-28 2005-02-09 Novartis Ag Amidas del acido piperidinilamino sulfamico o piperazinil sulfamico y su uso para la manufactura de un medicamento en enfermedades mediadas por la accion de la sulfatasa esteroide
HUE055755T2 (hu) * 2015-02-16 2021-12-28 Univ Queensland Szulfonolkarmabidok és rokon vegyületeik valamint felhasználásuk
PL3359541T3 (pl) * 2015-10-09 2021-01-11 AbbVie Overseas S.à r.l. N-SULFONYLOWANE PIRAZOLO[3,4-b]PIRYDYNO-6-KARBOKSAMIDY I SPOSÓB ZASTOSOWANIA
HK1257569A1 (zh) * 2016-02-16 2019-10-25 The University Of Queensland 磺醯脲和相关化合物及其用途
WO2017184604A1 (en) * 2016-04-18 2017-10-26 Ifm Therapeutics, Inc Compounds and compositions for treating conditions associated with nlrp activity
EP3272739A1 (en) * 2016-07-20 2018-01-24 NodThera Limited Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
US11236045B2 (en) * 2017-06-09 2022-02-01 Cadila Healthcare Limited Substituted sulfoximine compounds
GB201721185D0 (en) * 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
CN112672995A (zh) * 2018-08-15 2021-04-16 英夫拉索姆有限公司 新型磺酰胺脲化合物
GB201902327D0 (en) * 2019-02-20 2019-04-03 Inflazome Ltd Novel compounds

Similar Documents

Publication Publication Date Title
US20220169628A1 (en) Therapeutic agents and methods of treatment
JP2022536160A5 (OSRAM)
JP6125614B2 (ja) ピロロベンゾジアゼピン
JP2023540733A5 (OSRAM)
ES2905318T3 (es) Profármacos de riluzol y su uso
JP2021522276A5 (OSRAM)
FI3728238T3 (fi) Sulfonyyliureajohdannaisia nlrp3-inflammasomin moduulaattoreina
JP2018531289A5 (OSRAM)
RU2018105549A (ru) Производные бензодиазепина как ингибиторы rsv
JP2022507506A5 (OSRAM)
WO2013138753A1 (en) Prodrugs of riluzole and their method of use
JP2022535956A5 (OSRAM)
JP6938376B2 (ja) 多剤耐性菌に有効な新規アミノグリコシド抗生物質
ES2983661T3 (es) Derivados de sulfonilurea y usos de los mismos
JP2022507505A5 (OSRAM)
TW202329933A (zh) 咪唑并嗒𠯤ｉｌ—１７抑制劑化合物（一）
JP2023500662A (ja) イタコネートおよびメチルイタコネートの新規プロドラッグ
JP2022518526A5 (OSRAM)
KR102388412B1 (ko) 페노티아진 유도체 및 이의 사용 방법
JP2025504374A5 (OSRAM)
US8871983B2 (en) Lipid compounds for suppression of tumorigenesis
EP4514786A1 (en) Sting agonists, formulations, and uses thereof
RU2023108168A (ru) Производные сульфамоилмочевины, содержащие алкилоксациклоалкильную группу, и их применения
US20130296348A1 (en) Bis-Quinazoline Derivatives as Inhibitors for Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase
JP2020536860A (ja) 増殖性疾患、感染症、アレルギー、炎症及び／又は喘息を治療するためのｔｃｔｐ阻害剤